Publications by authors named "M Le Bert"

Claim this Profile
N
Nivolumab added to cisplatin and radiotherapy versus cisplatin and radiotherapy alone after surgery for people with squamous cell carcinoma of the head and neck at a high risk of relapse (GORTEC 2018-01 NIVOPOST-OP): a randomised, open-label, phase 3 trial.
Jean Bourhis, Anne Aupérin, Christian Borel, Gautier Lefebvre, Severine Racadot, Mahasti Bert

Lancet· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasmacytoid dendritic cells are dispensable or detrimental in murine systemic or respiratory viral infections.
Clemence Ngo, Camille Pierini-Malosse, Khalissa Rahmani, Michael Valente, Nils Collinet, Bertrand Escalière, Marc Le Bert

Nat Immunol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Butyrate receptor HCAR2/GPR109A controls imiquimod-induced psoriasis-like skin inflammation.
Lucija Leko, Darija Šimić, Timna Valera Martins, Gabriel Victor Lucena da Silva, Isabelle Maillet, Marc Le Bert

J Immunol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NLRP6 controls pulmonary inflammation from cigarette smoke in a gut microbiota-dependent manner.
Mégane Nascimento, Sarah Huot-Marchand, Manoussa Fanny, Marjolène Straube, Marc Le Bert

Front Immunol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lung inflammation and interstitial fibrosis by targeted alveolar epithelial type I cell death.
Sandra Carignon, Dorian De Moura Rodrigues, David Gosset, Elodie Culerier, Sarah Huot-Marchand, Marc Le Bert

Front Immunol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis